Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer

NCT04675697 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: Platinum-etoposide+Anlotinib

Sponsor

Xiangya Hospital of Central South University

Collaborators

[object Object]